儿科患者从大豆油基脂肪乳转换为混合脂肪乳
该回顾性队列研究纳入2016年5月至2019年9月某美国大型学术转诊中心1月龄至17岁需要肠外营养的患儿684例(其中342例危重),比较2017年全院从纯大豆油脂肪乳(IL组,206例)转换为大豆油/MCT/橄榄油/鱼油脂肪乳(4-OLE组,478例)前后的临床结局。多变量回归显示,全部儿童队列中4-OLE与住院时间缩短(IRR 0.81;95%CI 0.05-0.78)及尿路感染风险降低(OR 0.33;95%CI 0.18-0.64)相关;ICU队列中住院时间缩短(IRR 0.81;95%CI 0.78-0.83),尿路感染风险降低(OR 0.23;95%CI 0.11-0.51)。其他次要结局无显著差异。作者认为在儿科PN患者中转换为4-OLE是可行、安全的,并与临床结局改善相关。
要点
- 全部儿童队列中,4-OLE组较IL组住院时间缩短(IRR 0.81;95%CI 0.05-0.78),尿路感染风险降低(OR 0.33;95%CI 0.18-0.64)。
- ICU患儿队列中,4-OLE组较IL组住院时间缩短(IRR 0.81;95%CI 0.78-0.83),尿路感染风险降低(OR 0.23;95%CI 0.11-0.51)。
- 其他12项次要结局(包括全因住院死亡率、30天或90天再入院、肺炎、总热量供给及肝功能指标)在两组间无显著差异。
- 两组基线年龄中位数有显著差异(IL组4.0[1.2-13.0]岁 vs 4-OLE组3.0[0.8-9.0]岁;P=0.04),癌症诊断(12.6% vs 6.1%;P=0.004)和慢性阻塞性肺疾病(11.7% vs 6.3%;P=0.02)比例亦有显著差异。
- 作者认为,在儿科PN患者中转换为4-OLE是可行、安全的,并与临床结局改善相关。
适用人群与场景
- 2016年5月至2019年9月在某美国大型学术转诊中心接受肠外营养的1月龄至17岁儿科患者,共684例,其中342例为危重患儿。
- 4-OLE组478例(70%),IL组206例(30%);IL组男性123例(59.7%),按原文所述123例为男性。
处置流程与药物剂量
- 2017年某大学卫生系统在儿科患者中将纯大豆油基脂肪乳(Intralipid)全面转换为大豆油/MCT/橄榄油/鱼油脂肪乳(4-OLE)。
研究设计与关键结果
- 回顾性队列研究,纳入684例依赖肠外营养的患儿(342例危重),比较IL组(206例)与4-OLE组(478例)。
- 全部儿童队列:4-OLE与住院时间缩短相关(IRR 0.81;95%CI 0.05-0.78),与尿路感染风险降低相关(OR 0.33;95%CI 0.18-0.64)。
- ICU队列:4-OLE与住院时间缩短相关(IRR 0.81;95%CI 0.78-0.83),与尿路感染风险降低相关(OR 0.23;95%CI 0.11-0.51)。
- 其他次要结局(包括全因住院死亡率、30天或90天再入院、肺炎、总热量供给及肝功能指标)无显著差异。
- 基线比较:年龄中位数IL组4.0(IQR 1.2-13.0)岁 vs 4-OLE组3.0(IQR 0.8-9.0)岁,P=0.04;癌症诊断IL组26例(12.6%) vs 4-OLE组29例(6.1%),P=0.004;慢性阻塞性肺疾病IL组24例(11.7%) vs 4-OLE组30例(6.3%),P=0.02;体质指数及基线合并症无差异。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在儿科肠外营养患者中转换为4-OLE是可行、安全的,并与临床结局改善相关。
- 原文指出该转换为观察性研究,转换为4-OLE与ICU及非ICU患儿住院时间显著缩短相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Critically ill pediatric patients often require parenteral nutrition (PN) in the intensive care unit (ICU). Literature suggests mixed lipid emulsions (LE) with soybean oil reduction strategies may improve outcomes.
OBJECTIVE: To examine the association of a hospital-wide switch to a mixed-lipid formula (4-OLE) with pediatric outcomes.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study at a large US academic referral center. Pediatric patients aged 1 month to 17 years requiring parenteral nutrition from May 2016 to September 2019 were included. Data were analyzed from October 2020 to February 2023.
EXPOSURE: In 2017, Duke University Health System fully converted to a soybean oil/MCT/olive/fish oil lipid (4-OLE) from pure soybean oil-based LE in pediatric patients. Pediatric patients before the change (Intralipid [IL] group) were compared with patients after (4-OLE group).
MAIN OUTCOMES AND MEASURES: Clinical outcomes were compared between treatment periods via multivariable regression models. The primary outcome was hospital length of stay (LOS). Fourteen secondary outcomes included hospital mortality of any cause, 30-day or 90-day readmission, pneumonia, urinary tract infections (UTIs), total caloric delivery, and liver function tests (aspartate aminotransferase, alanine transaminase, alkaline phosphatase, and total bilirubin).
RESULTS: A total of 684 children dependent on PN were identified (342 were critically ill), with 30% (206 children) in the preswitch (IL) period and 70% (478 children) in the postswitch (4-OLE) period; 123 were male (59.7%). In comparing IL vs 4-OLE, there was a significant difference in median (IQR) age (4.0 [1.2-13.0] vs 3.0 [0.8-9.0] years, respectively; P = .04), without difference in body mass index or baseline comorbidities except for significant differences in cancer diagnosis (26 patients in the IL group [12.6%] vs 29 patients in the 4-OLE group [6.1%]; P = .004) and chronic obstructive pulmonary disease (24 patients in the IL group [11.7%] vs 30 patients in the 4-OLE group [6.3%]; P = .02). In the all children cohort, 4-OLE was associated with shorter hospital LOS (IRR, 0.81; 95% CI, 0.05-0.78), and reduced UTI risk (OR, 0.33; 95% CI, 0.18-0.64). In the ICU cohort, 4-OLE was associated with shorter hospital LOS (IRR, 0.81; 95% CI, 0.78-0.83), and reduced UTI risk (OR, 0.23; 95% CI, 0.11-0.51). Other secondary outcomes were not significant.
CONCLUSIONS AND RELEVANCE: In this observational study of clinical outcomes among children dependent on PN, a switch to 4-OLE in a large academic hospital was associated with a significant decrease in hospital LOS in ICU and non-ICU patients. These findings suggest switching to a soy-LE sparing strategy using 4-OLE is feasible, safe, and associated with improved clinical outcomes in pediatric PN patients.
参考来源
- Haines KL, Ohnuma T, Hornik CD, et al. Change to Mixed-Lipid Emulsion From Soybean Oil-Based Lipid Emulsion in Pediatric Patients. JAMA Netw Open. 2023. PMID: 37669048. doi:10.1001/jamanetworkopen.2023.32389
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。